未登录

R

R Wild

adelphi group ltd

H指数:6

被引数:175

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Describing the burden of moderate exacerbations in patients with asthma from the Extended Salford Lung Study (Ext-SLS): a retrospective cohort study

描述哮喘患者中度急性加重负担的Extended Salford Lung Study（Ext-SLS）扩展萨尔福德肺脏研究：一项回顾性队列研究

RESPIRATORY RESEARCH

IF5

2025-03-290

OA

Achievement of HbA1c and weight targets in adults with type 2 diabetes on once weekly injectable glucagon-like peptide-1 receptor agonist therapy in UK primary care: A retrospective, real-world study

英国初级保健中每周一次注射胰高血糖素样肽-1受体激动剂治疗成人2型糖尿病患者HbA1c和体重目标的实现: 一项回顾性真实世界研究

DIABETES OBESITY & METABOLISM

IF5.7

2025-01-220

OAAI

Validation of an EMR derived algorithm to identify moderate asthma exacerbations in the UK

EUROPEAN RESPIRATORY JOURNAL

IF21

2023-10-270

PRE

Burden of Fatigue Among Patients with Ulcerative Colitis and Crohn's Disease: Results from a Global Survey of Patients and Gastroenterologists

ADVANCES IN THERAPY

IF4

2022-11-1216

OAAI

Characterisation of patients with chronic obstructive pulmonary disease initiating single-device inhaled corticosteroids/long-acting β2-agonist dual therapy in a primary care setting in England

BMJ OPEN RESPIRATORY RESEARCH

IF3.4

2022-09-281

OAAI

Are patients with COPD more adherent to single-inhaler compared with multiple-inhaler triple therapy in a real-world UK primary care treated population?

EUROPEAN RESPIRATORY JOURNAL

IF21

2021-11-253

PRE

Characteristics and treatment pathways of patients with COPD receiving an inhaled corticosteroid/long-acting β2-agonist (ICS/LABA) in the UK

EUROPEAN RESPIRATORY JOURNAL

IF21

2021-11-251

PRE

Characteristics and treatment pathways of patients with COPD receiving a long-acting muscarinic antagonist/long-acting β2-agonist (LABA/LAMA) in the UK

EUROPEAN RESPIRATORY JOURNAL

IF21

2021-11-250

PRE

ARE PATIENTS WITH COPD MORE ADHERENT TO FLUTICASONE FUROATE/UMECLIDINIUM/VILANTEROL (FF/UMEC/VI) COMPARED WITH MULTIPLE-INHALER TRIPLE THERAPY IN A REAL-WORLD UK PRIMARY CARE TREATED POPULATION?

IF7.7

2021-11-082

OA

Health-Related Quality of Life Among Patients With HR+/HER2-Early Breast Cancer

HR /HER2-Early乳腺癌患者的健康相关生活质量

CLINICAL THERAPEUTICS

IF3.6

2021-07-0113

PREAI

Impact of clinical characteristics, patients' perception of treatment goals and endocrine therapy history on HRQOL in HR+, HER2-early stage breast cancer patients

ANNALS OF ONCOLOGY

IF65.4

2020-09-011

OAAI

Germline BRCA1/2 (gBRCA1/2) testing patterns among oncologists (ONC) treating HER2-advanced breast cancer (ABC): Results from a multi-country real-world study

ANNALS OF ONCOLOGY

IF65.4

2020-05-012

OAAI